Sarah Jiaxi Wu, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sigmoid Neoplasms | 1 | 2020 | 55 | 0.680 |
Why?
|
| Brucella suis | 1 | 2018 | 2 | 0.640 |
Why?
|
| Brucellosis | 1 | 2018 | 21 | 0.630 |
Why?
|
| Vascular Fistula | 1 | 2018 | 50 | 0.610 |
Why?
|
| Bronchial Fistula | 1 | 2018 | 83 | 0.600 |
Why?
|
| Aneurysm, Infected | 1 | 2018 | 82 | 0.590 |
Why?
|
| Aortitis | 1 | 2018 | 77 | 0.580 |
Why?
|
| Colonic Polyps | 1 | 2020 | 557 | 0.480 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2018 | 708 | 0.390 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 1926 | 0.370 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 4282 | 0.290 |
Why?
|
| GATA3 Transcription Factor | 1 | 2024 | 163 | 0.220 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5861 | 0.220 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2023 | 36 | 0.210 |
Why?
|
| SOXC Transcription Factors | 1 | 2023 | 41 | 0.210 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 6359 | 0.200 |
Why?
|
| Interferon Regulatory Factors | 1 | 2023 | 272 | 0.190 |
Why?
|
| Colon, Sigmoid | 1 | 2020 | 124 | 0.170 |
Why?
|
| Nephrectomy | 1 | 2024 | 928 | 0.160 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2024 | 1131 | 0.160 |
Why?
|
| Carcinoma, Papillary | 1 | 2024 | 791 | 0.160 |
Why?
|
| Animals, Wild | 1 | 2018 | 78 | 0.150 |
Why?
|
| Organoplatinum Compounds | 1 | 2020 | 406 | 0.150 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2018 | 33 | 0.150 |
Why?
|
| Leucovorin | 1 | 2020 | 644 | 0.150 |
Why?
|
| Zoonoses | 1 | 2018 | 180 | 0.140 |
Why?
|
| Bacteriological Techniques | 1 | 2018 | 277 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1762 | 0.130 |
Why?
|
| Debridement | 1 | 2018 | 494 | 0.130 |
Why?
|
| Fluorouracil | 1 | 2020 | 1651 | 0.120 |
Why?
|
| Colectomy | 1 | 2020 | 696 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 1057 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2018 | 698 | 0.110 |
Why?
|
| Cerebellar Neoplasms | 1 | 2018 | 588 | 0.110 |
Why?
|
| Medulloblastoma | 1 | 2018 | 679 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2023 | 2926 | 0.100 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 723 | 0.100 |
Why?
|
| Oncogenes | 1 | 2018 | 1231 | 0.100 |
Why?
|
| Colonoscopy | 1 | 2020 | 1409 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2023 | 2747 | 0.100 |
Why?
|
| Electron Transport Complex II | 1 | 2011 | 53 | 0.090 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 3552 | 0.090 |
Why?
|
| Succinic Acid | 1 | 2011 | 86 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2018 | 2931 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 1964 | 0.090 |
Why?
|
| Surgical Flaps | 1 | 2018 | 1680 | 0.080 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2024 | 3186 | 0.080 |
Why?
|
| Oxidative Phosphorylation | 1 | 2011 | 502 | 0.080 |
Why?
|
| Swine | 1 | 2018 | 5987 | 0.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2018 | 1456 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2022 | 8621 | 0.080 |
Why?
|
| Biopsy | 1 | 2018 | 6779 | 0.070 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 1029 | 0.060 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 980 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2011 | 882 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2018 | 4427 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5387 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2011 | 1474 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 9611 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 7475 | 0.040 |
Why?
|
| Mutation | 1 | 2024 | 30213 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2022 | 10445 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11872 | 0.040 |
Why?
|
| Aged | 2 | 2024 | 171343 | 0.040 |
Why?
|
| Humans | 6 | 2024 | 766766 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2018 | 12150 | 0.040 |
Why?
|
| Mitochondria | 1 | 2011 | 3677 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2018 | 190 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 13485 | 0.030 |
Why?
|
| Epithelium | 1 | 2022 | 1606 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2018 | 247 | 0.030 |
Why?
|
| Animals | 5 | 2022 | 168930 | 0.030 |
Why?
|
| Genes, ras | 1 | 2018 | 656 | 0.030 |
Why?
|
| Acetylation | 1 | 2018 | 1054 | 0.030 |
Why?
|
| Male | 3 | 2024 | 364142 | 0.030 |
Why?
|
| Female | 3 | 2024 | 396520 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2022 | 14471 | 0.030 |
Why?
|
| Lysine | 1 | 2018 | 997 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2018 | 751 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 17088 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 65273 | 0.020 |
Why?
|
| Ion Transport | 1 | 2011 | 322 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 223257 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1604 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 4049 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 5199 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 223307 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 1874 | 0.010 |
Why?
|
| Cell Line | 1 | 2018 | 15563 | 0.010 |
Why?
|
| Longevity | 1 | 2011 | 1083 | 0.010 |
Why?
|
| Lung | 1 | 2022 | 10067 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2018 | 12791 | 0.010 |
Why?
|
| Mice | 2 | 2022 | 81889 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11920 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29948 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 23619 | 0.010 |
Why?
|